Lili Chen

4PUBLICATIONS
9CO-AUTHORS
Molecular medicineCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 13, 2025
Exploring anti-SARS-CoV-2 natural products: dual-viral target inhibition by delphinidin and the anti-coronaviral efficacy of deapio platycodin D.

Jiani Lu, Yan Tang, Hongtao Li

|Mar 13, 2025
Identifying Exifone as a Dual-Target Agent Targeting Both SARS-CoV-2 3CL Protease and the ACE2/S-RBD Interaction Among Clinical Polyphenolic Compounds.

Jiani Lu, Yan Tang, Hongtao Li

|Apr 01, 2024
Promising natural products targeting protein tyrosine phosphatase SHP2 for cancer therapy.

Jiani Lu, Danmei Yu, Hongtao Li

|Jul 08, 2021
The Cyr61 Is a Potential Target for Rotundifuran, a Natural Labdane-Type Diterpene from Vitex trifolia L., to Trigger Apoptosis of Cervical Cancer Cells.

Gang Gong, Yu-Li Shen, Hai-Yue Lan

Pageof 1

Frequent Collaborators

1 joint publications

Gang Gong

1 joint publications

Yu-Li Shen

1 joint publications

Hai-Yue Lan

1 joint publications

Jin-Mei Jin